Dynex Capital, Inc. (DX) Financial Statements
Dynex Capital, Inc. (DX) reported trailing twelve-month revenue of $533.5M (up 67.0% year on year) and net income of $436.2M as of 2026-06-30, according to EquiReason's reading of its SEC filings. Free cash flow over the same period: $236.6M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
- Market cap
- 2.7B
- P/E TTM
- 5.7
- Dividend yield
- 18.7%
- 52-week
- —
- Next earnings
- 25 Jan, in 93 days
Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Jun 26. Results for the next quarter were released 19 Oct; these figures move once the 10-Q is filed.
| Line | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.11 | 0.10 | 0.09 | 0.09 | 0.11 | 0.17 | 0.21 | 0.32 | 0.53 | — | |
| Pre-tax income | 0.03 | 0.02 | 0.04 | 0.03 | 0.01 | -0.15 | -0.01 | 0.11 | 0.32 | 0.44 | |
| Net income | 0.03 | 0.02 | 0.04 | 0.03 | 0.01 | -0.15 | -0.01 | 0.11 | 0.32 | 0.44 | |
| Diluted EPS ($) | 0.34 | 0.14 | 0.69 | 1.37 | -0.25 | -7.01 | -0.25 | 1.49 | 2.47 | 1.91 | |
| Diluted shares (bn) | 0.055 | — | — | — | — | 0.024 | 0.055 | 0.071 | 0.125 | — |
USD billions · SEC XBRL
Dynex Capital, Inc. — questions
- What is Dynex Capital, Inc.'s revenue?
- $533.5M over the twelve months to 2026-06-30, up 67.0% year on year, from its 10-Q and 10-K filings.
- What is Dynex Capital, Inc.'s net income?
- $436.2M over the twelve months to 2026-06-30.
- What is Dynex Capital, Inc.'s free cash flow?
- $236.6M over the twelve months to 2026-06-30.
- What are Dynex Capital, Inc.'s diluted earnings per share?
- $1.91 over the twelve months to 2026-06-30.
Every figure on this page comes from Dynex Capital, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.